CN103550126A - 一种生物祛痘淡痕修复乳 - Google Patents
一种生物祛痘淡痕修复乳 Download PDFInfo
- Publication number
- CN103550126A CN103550126A CN201310551592.1A CN201310551592A CN103550126A CN 103550126 A CN103550126 A CN 103550126A CN 201310551592 A CN201310551592 A CN 201310551592A CN 103550126 A CN103550126 A CN 103550126A
- Authority
- CN
- China
- Prior art keywords
- gram
- grams
- acne
- skin
- hirudin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title abstract description 12
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract description 11
- 239000000839 emulsion Substances 0.000 title abstract 6
- 102000007625 Hirudins Human genes 0.000 claims abstract description 21
- 108010007267 Hirudins Proteins 0.000 claims abstract description 21
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims abstract description 21
- 229940006607 hirudin Drugs 0.000 claims abstract description 21
- 150000001413 amino acids Chemical class 0.000 claims abstract description 17
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims abstract description 17
- 101800003838 Epidermal growth factor Proteins 0.000 claims abstract description 16
- 102000000588 Interleukin-2 Human genes 0.000 claims abstract description 16
- 108010002350 Interleukin-2 Proteins 0.000 claims abstract description 16
- 229940116977 epidermal growth factor Drugs 0.000 claims abstract description 16
- 210000002826 placenta Anatomy 0.000 claims abstract description 14
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 210000002374 sebum Anatomy 0.000 claims abstract description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 7
- 102000014171 Milk Proteins Human genes 0.000 claims abstract description 7
- 108010011756 Milk Proteins Proteins 0.000 claims abstract description 7
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 7
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 7
- 235000021239 milk protein Nutrition 0.000 claims abstract description 7
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 7
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 7
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 7
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims abstract 4
- 235000001014 amino acid Nutrition 0.000 claims description 15
- 235000018102 proteins Nutrition 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 241000283898 Ovis Species 0.000 claims description 13
- 230000003255 anti-acne Effects 0.000 claims description 12
- 210000000481 breast Anatomy 0.000 claims description 11
- 239000003906 humectant Substances 0.000 claims description 6
- 210000004698 lymphocyte Anatomy 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000005457 optimization Methods 0.000 claims description 3
- 239000011550 stock solution Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 230000003750 conditioning effect Effects 0.000 abstract description 7
- 230000004089 microcirculation Effects 0.000 abstract description 6
- 230000007969 cellular immunity Effects 0.000 abstract description 4
- 241001494479 Pecora Species 0.000 abstract description 3
- 208000003455 anaphylaxis Diseases 0.000 abstract description 3
- 230000002087 whitening effect Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract 2
- 239000003531 protein hydrolysate Substances 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 1
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 230000001153 anti-wrinkle effect Effects 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- -1 ethyl ascorbic acid Chemical compound 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 28
- 102400001368 Epidermal growth factor Human genes 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 9
- 239000000126 substance Substances 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 241000700647 Variola virus Species 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108090000190 Thrombin Proteins 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 229960004072 thrombin Drugs 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010040867 Skin hypertrophy Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310551592.1A CN103550126A (zh) | 2013-11-08 | 2013-11-08 | 一种生物祛痘淡痕修复乳 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310551592.1A CN103550126A (zh) | 2013-11-08 | 2013-11-08 | 一种生物祛痘淡痕修复乳 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103550126A true CN103550126A (zh) | 2014-02-05 |
Family
ID=50004613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310551592.1A Pending CN103550126A (zh) | 2013-11-08 | 2013-11-08 | 一种生物祛痘淡痕修复乳 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103550126A (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104997651A (zh) * | 2015-08-14 | 2015-10-28 | 广州雅您儿生物科技有限公司 | 细胞活化再生营养素 |
CN105997559A (zh) * | 2016-05-11 | 2016-10-12 | 南京泽丽生物技术有限公司 | 一种美肤抗痘组合物及其制备方法 |
CN107510619A (zh) * | 2017-09-06 | 2017-12-26 | 深圳肽之妃科技有限公司 | 一种复合多肽面膜及其制备方法 |
CN107519037A (zh) * | 2017-09-06 | 2017-12-29 | 深圳肽之妃科技有限公司 | 一种含多肽的液体面膜及其制备方法和使用方法 |
CN109381357A (zh) * | 2018-12-13 | 2019-02-26 | 广州宝莱生物科技有限公司 | 一种祛痘润肤水蛭冻干粉 |
CN111067839A (zh) * | 2020-01-16 | 2020-04-28 | 广东丽姿生物科技有限公司 | 一种调理修护剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1522689A (zh) * | 2003-09-12 | 2004-08-25 | 周维海 | 水蛭提取物美容化妆品及其制备方法 |
CN102307561A (zh) * | 2008-06-30 | 2012-01-04 | 奥夫莱夫塔埃克尼公司 | 植物来源的重组生长因子在皮肤护理中的应用 |
-
2013
- 2013-11-08 CN CN201310551592.1A patent/CN103550126A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1522689A (zh) * | 2003-09-12 | 2004-08-25 | 周维海 | 水蛭提取物美容化妆品及其制备方法 |
CN102307561A (zh) * | 2008-06-30 | 2012-01-04 | 奥夫莱夫塔埃克尼公司 | 植物来源的重组生长因子在皮肤护理中的应用 |
Non-Patent Citations (2)
Title |
---|
邹全明 等: "《基因工程技术在美容保健品中的应用》", 《第十届东南亚地区医学美容学术交流大会论文汇编》, 31 December 2006 (2006-12-31), pages 8 - 11 * |
阮传良 等: "《若干生化产品在功效化妆品开发中的应用》", 《2007(第六届)中国日用化学工业研讨会论文集》, 31 December 2007 (2007-12-31), pages 75 - 82 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104997651A (zh) * | 2015-08-14 | 2015-10-28 | 广州雅您儿生物科技有限公司 | 细胞活化再生营养素 |
CN105997559A (zh) * | 2016-05-11 | 2016-10-12 | 南京泽丽生物技术有限公司 | 一种美肤抗痘组合物及其制备方法 |
CN107510619A (zh) * | 2017-09-06 | 2017-12-26 | 深圳肽之妃科技有限公司 | 一种复合多肽面膜及其制备方法 |
CN107519037A (zh) * | 2017-09-06 | 2017-12-29 | 深圳肽之妃科技有限公司 | 一种含多肽的液体面膜及其制备方法和使用方法 |
CN107510619B (zh) * | 2017-09-06 | 2020-11-24 | 深圳肽之妃科技有限公司 | 一种复合多肽面膜及其制备方法 |
CN109381357A (zh) * | 2018-12-13 | 2019-02-26 | 广州宝莱生物科技有限公司 | 一种祛痘润肤水蛭冻干粉 |
CN109381357B (zh) * | 2018-12-13 | 2021-09-03 | 广州宝莱生物科技有限公司 | 一种祛痘润肤水蛭冻干粉 |
CN111067839A (zh) * | 2020-01-16 | 2020-04-28 | 广东丽姿生物科技有限公司 | 一种调理修护剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103550126A (zh) | 一种生物祛痘淡痕修复乳 | |
Pan et al. | Placental therapy: An insight to their biological and therapeutic properties | |
CN103271837B (zh) | 生物活性化妆品配方及其制作方法 | |
CN103550117A (zh) | 可促进皮肤修复与再生的美容护肤品及其制备方法和应用 | |
CN104173251A (zh) | 一种牦牛骨胶原肽美白面膜及其制备方法 | |
KR20160064410A (ko) | 스피큘을 포함하는 피부관리용 화장품 조성물 및 이의 제조방법 | |
CN1259034C (zh) | 水蛭提取物美容化妆品及其制备方法 | |
CN105193673B (zh) | 一种清痘修复液及其制备方法 | |
CN101791283B (zh) | 一种可消除妊娠纹和疤痕的化妆品 | |
CN113318058A (zh) | 胶原蛋白补充剂、射频美容用自体胶原蛋白液及其使用方法和应用 | |
CN105616184A (zh) | 一种透明质酸多肽键合物面膜及其制备方法 | |
CN113332162A (zh) | 一种鱼精蛋白-pdrn复合物、组合物及在制备护肤产品中的应用 | |
CN108261367A (zh) | 一种抗衰老保湿精华液及其制备方法 | |
CN103800224A (zh) | 护理皮肤用的美容组合物及美容方法 | |
CN103690393B (zh) | 美白抗皱生物蚕丝面膜 | |
CN108498357A (zh) | 一种类人胶原蛋白面膜液及其制作方法 | |
CN110368347A (zh) | 一种抗衰修复双层双色精华素及其制备方法 | |
CN104546591A (zh) | 一种植物精油面膜及其制备方法 | |
CN110522712A (zh) | 一种坏脸修护精华及制备方法 | |
CN103705394B (zh) | 祛痘消痕生物蚕丝面膜 | |
CN100546564C (zh) | 中药瓜果美容敷面膏及制备方法 | |
CN103520708A (zh) | 一种能促进创伤愈合、减少疤痕形成的组合物 | |
CN111067860A (zh) | 一种用于美白和淡化痘印的干细胞分泌因子面膜及其制备方法 | |
CN108309840A (zh) | 一种专业修复膜面膜液及其制作方法 | |
CN104721126A (zh) | 赋活修护精华素及其制剂生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGDONG LIZI BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WANG HONGBO Effective date: 20150709 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150709 Address after: 528300, No. 9, building 1, 1-2 East Avenue, Ronggui Desheng neighborhood committee, Shunde District, Foshan, Guangdong Applicant after: Guangdong Lizi Biotechnology Co., Ltd. Address before: Garden Road Shunde District Ronggui street 528303 Silver City Sports in Guangdong province Foshan city 3 Building No. 201 Applicant before: Wang Hongbo |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140205 |